Boehringer Ingelheim Collaboration with Viratherapeutics

News   Sep 29, 2016

 
Boehringer Ingelheim Collaboration with Viratherapeutics
 
 
 

RELATED ARTICLES

Inflammation Causes Chemo Brain

News

The research could lead to a new practice of identifying inflammatory biomarkers in cancer patients and then treating the inflammation with medications or exercise to improve cognition and other symptoms.

READ MORE

What Does the Future of Vaccines and Immunotherapy Look Like?

News

Innovative biomaterials could enhance vaccines against HIV and other infectious diseases and immunotherapies for patients with cancer or dampen responses in autoimmune disorders, allergies and transplanted organ recipients. A review of these efforts was recently released.

READ MORE

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE